{"id":439927,"date":"2021-02-19T09:03:23","date_gmt":"2021-02-19T14:03:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=439927"},"modified":"2021-02-19T09:03:23","modified_gmt":"2021-02-19T14:03:23","slug":"bluebird-bio-inc-class-action-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-securities-class-action-lawsuit-has-been-filed-in-the-united-states-district-court-for-the-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bluebird-bio-inc-class-action-alert-wolf-haldenstein-adler-freeman-herz-llp-announces-that-a-securities-class-action-lawsuit-has-been-filed-in-the-united-states-district-court-for-the-2\/","title":{"rendered":"BLUEBIRD BIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against bluebird bio, Inc."},"content":{"rendered":"
\n

LEAD PLAINTIFF DEADLINE IS APRIL 13, 2021<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span>, Feb. 19, 2021<\/span> \/PRNewswire\/ — Wolf Haldenstein Adler Freeman<\/span> & Herz LLP <\/a>\u00a0announces that a announces that a federal securities class action lawsuit has been filed in\u00a0 the\u00a0 United States<\/span> District Court for the Eastern District of New York\u00a0against\u00a0 bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired bluebird\u00a0securities\u00a0between May 11<\/span>, 2020\u00a0and\u00a0November 4, 2020, both dates inclusive (the “Class Period”).\u00a0<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Wolf
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n All <\/b>
\n investors\u00a0who purchased shares <\/b>
\n of<\/b>\u00a0bluebird bio, Inc<\/b>. and<\/b> incurred losses are u<\/b>rged<\/b> to contact the firm immediately at classmember@whafh.com<\/a> or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case<\/a> on our website, www.whafh.com.<\/a><\/b><\/p>\n

If \u00a0\u00a0you have incurred losses in the \u00a0shares of bluebird bio, Inc<\/b>., you<\/b>\u00a0<\/b>may,<\/b>no later than April 13, 2021<\/span><\/b>, <\/b>request that the Court appoint you lead plaintiff of the proposed class.\u00a0 Please contact Wolf Haldenstein<\/span><\/a> to learn more about your rights as an investor in the shares of bluebird bio, <\/b>Inc.<\/b>\u00a0<\/p>\n

\n
\n CLICK HERE TO JOIN CASE<\/a>
\n <\/b>\n <\/p>\n

The filed complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and failed to disclose to investors that:<\/p>\n